Effects of neurotransmitters and neuropharmacological agents on phospholipid metabolism in the rabbit iris muscle.
D000109:Acetylcholine / Q000494:pharmacology*; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000375:Aging; D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D002118:Calcium / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology*; D066298:In Vitro Techniques; D007498:Iris / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism*; D009638:Norepinephrine / Q000494:pharmacology; D010712:Phosphatidic Acids / Q000378:metabolism; D010713:Phosphatidylcholines / Q000378:metabolism; D010714:Phosphatidylethanolamines / Q000378:metabolism; D010716:Phosphatidylinositols / Q000378:metabolism; D010743:Phospholipids / Q000378:metabolism*; D010830:Physostigmine / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D010712:Phosphatidic Acids; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D010716:Phosphatidylinositols; D010743:Phospholipids; D001285:Atropine; D002217:Carbachol; D010830:Physostigmine; D011433:Propranolol; D000109:Acetylcholine; D002118:Calcium; D009638:Norepinephrine